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Introduction
Nowadays, cancer is one of the most important concerns 
worldwide and has persuaded many scientists to perform 
extensive studies to know more about the mechanism 
underlying its development and also the approaches to 
prevent and cure the disease.1,2 Prostate cancer (PC) is the 
most prevalent cancer in men and is the second leading 
cause of death due to cancer after lung cancer in males.3 
PC is initially dependent on androgens for proliferation, 
but eventually progresses to be androgen-independent 
phenotype PC in the androgen-independent phenotype 
becomes highly resistant to chemotherapy in advanced 
stages of the disease.4Androgen ablation therapy is mainly 
used for the treatment of hormone-sensitive PC. However, 
in most men usually after 2 to 3 years, metastatic PC 
leads to an androgen-independent state.5 Many of the 
natural plant ingredients play an important role in cancer 
prevention.6 These natural compounds such as alkaloids, 
terpenes, lignans and flavonoids in various plants have 
anti-tumor properties.7 Thymoquinone (2-isopropyl-
5-methyl-1,4-benzoquinone) (TQ) is a bioactive plant 
ingredient which is abundantly found in plants such 
as Nigella sativa Linn.8 TQ has been reported to have 
antioxidant,9 anti-inflammatory,10 anti-neoplastic11 
and anti-poisoning activities in malignancies such as 
PC,12 osteosarcoma,13 fibro sarcoma14 and myeloblastic 
leukemia.15 This compound has a strong antioxidant effect 
by which it prevents tumor cell growth in many cancers.16
Inhibition of cancer cell growth is often achieved by the 
activation of apoptotic regulatory factors. BCL-2, MCL-
1and BCL-XL have been identified as three important 
factors in this pathway.17 BCL-2 family plays a key role 
in regulation and inhibition of apoptosis and increase 
in its activity gives rise to a wide spectrum of cancers.18 
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Abstract
Purpose: Since active plant ingredients can induce apoptosis in many tumors, in this study 
we evaluate the apoptotic effects of thymoquinone (TQ) on PC3 cells. Also, we predicted the 
interaction of TQ with BCL-XL, BCL-2, and MCL-1anti-apoptotic factors by computer-simulated 
environment.
Methods: PC3 cells were treated with different concentrations of TQ (0- 80 µM) and IC50 was 
determined using 3-(4, 5-dimethylthiaztol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. 
Apoptotic and cytotoxicity effects of TQ were analyzed using flowcytometry and comet assay, 
respectively. Changes in energy and the molecular interactions of TQ with BCL-XL, BCL-2 and 
MCL-1 anti-apoptotic factors were investigated using simulation.
Results: IC50 value was 40 µM. TQ led to the destruction of the genome of PC3 cells and inducing 
apoptosis. Molecular dynamics (MD) revealed that the root mean-square deviation (RMSD), 
root mean square fluctuation (RMSF), radius of gyration (Rg), and the number of hydrogen and 
hydrophobic bonds between TQ and residues of BCL-2, BCL-XL and MCL-1were significantly 
(P < 0.001) changed. TQ makes a more stable and stronger connection with BCL-XL compared 
to BCL-2 and MCL-1 and inhibits BCL-XL non-competitively.
Conclusion: Our results demonstrated that TQ not only led to apoptosis, at least partly, due to 
reduction in the Coil, Turn, and Bend structure of BCL-XL but also caused a decrease in the Rg 
and RMSD value of BCL-XL, MCL-1, and BCL-2.
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Reduction in BCL-2 gene expression is the hallmark of 
the beginning of apoptosis which reinforces the effects 
of anti-tumor therapy. Over expression of BCL-2 causes 
resistance to anti-cancer therapy. BCL-2 interacts with a 
subset of pre-apoptotic molecules including BAD, BAX, 
BIM, BAK, BID, and BIK directly.19 Also, BCL-XL and 
MCL-1, as anti-apoptotic factors, play a critical role in 
the inhibition of apoptosis.20 Therefore, the aim of this 
study was to determine the genotoxic effects of TQ on 
PC3 cell line as well as predicting interactional molecular 
dynamic (MD) mechanisms of TQ with BCL-XL, BCL-2, 
and MCL-1 anti-apoptotic factors by computer-simulated 
environment based on molecular docking software (Auto 
Dock, Gromacs and VMD). 
Materials and Methods
The human PC cell line, PC3, was purchased from 
Pasteur Institute of Iran (Tehran, Iran). TQ was obtained 
from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, 
USA). RPMI 1640 medium and fetus bovine serum 
(FBS) were prepared from Gibco (Rockville, MD, USA). 
Pen/Strep antibiotics were purchased from Abcam (San 
Francisco, CA, USA). 3-(4,5-dimethylthiaztol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) was purchased from 
Sigma-Aldrich (St. Louis, MO). All other chemicals used 
were of analytical grade.
Experimental Methods
Cell culture
PC3 cell line was cultured in RPMI1640 medium 
supplemented with 10%heat-inactivated FBS, penicillin 
(100 U/mL) and streptomycin (100 U/mL). The flasks 
were kept in a humidified incubator containing 5% CO2 
at 37°C.21
Cell viability
The viability of cells against cytotoxic effects of TQ was 
performed by MTT colorimetric assay. Briefly, 5×103 
cells were cultured in a 96-well plate containing RPMI 
1640 phenol-red free medium, supplemented with 10% 
FBS. After overnight incubation, cells were treated with 
different concentrations of TQ (0- 80 µM) for 48 h in a 
humidified 5% CO2 incubator.21 Then, cells were treated 
with 12mM MTT solution and were incubated for 4 h. 
Optical density was measured at 490 nm with 670 nm 
as the reference wavelength by a micro plate reader (Stat 
Fax-2100, Spain). Each test was carried out in triplicate. 
Viability percentage was calculated as follows: (OD value 
of treated group/OD value of control group) 100× and 
non-treated cell viability was set as 100%.22
Alkaline electrophoresis and comet assay
Based on IC50 value, 20 and 30 µM of TQ concentrations 
(two concentrations lower than IC50) were used in alkaline 
electrophoresis. PC3 untreated cells were used as negative 
control and positive control was treated with 50µM 
H2O2.23 Slides were cleaned by methanol and heated gently. 
A 300 µL of 1% agarose dissolved in PBS was poured on 
slides and after inserting lamella, the slides were put on 
ice packs to harden the first agarose layer. Slides were 
incubated at 37°C for 24 h, after removing lamella. 10 
µL of prepared cells was mixed with 80 µL of 1 % low 
melting point agarose in PBS. Then, 10 µL of the solution 
was poured over the first layer of agarose and the lamella 
was immediately inserted to make the middle layer. The 
third layer of agarose was made using 1% agarose in PBS. 
Slides were incubated for 24hin lysis buffer containing 
100 mM Na2 EDTA, 10% DMSO and 2.5 mM NaCl, pH 
10, and 1% triton X-100. In the next step, slides exposed 
to alkaline buffer solution containing 1 mM Na2EDTA, 
0.3 M NaCl and pH=13 for 30 minutes. The slides were 
subjected to electrophoresis (25V, 300 mA, and 40 min). 
Then, slides were rinsed three times using neutralizing 
solution comprising 0.4M Tris HCl (pH 7.5). Slides were 
fixed in 95% ethanol three times, stained in 20 µg/mL 
ethidium bromide and finally analyzed using fluorescent 
microscope with 40X magnification (Olympuse BX51, 
Tokyo, Japan). One hundred cell images were analyzed for 
each concentration using CASP v.1.2.2 software.24
Flowcytometry
PC3 cells were cultured in 6-well plates at a density 
of 1 × 104/well and were treated with three different 
concentrations of TQ (20, 30, and 40 µM). After treating 
PC3 cells with TQ for 48h, cells were harvested and 
washed twice with PBS. Then, the PC3 cells were mixed 
with binding buffer and incubated with an annexin-V/
PI double staining solution at room temperature for 15 
minutes according to the manufacture’s protocol. Then, 
the 12 000 stained cells were analyzed by flow cytometry 
and the percentage of apoptotic cells was calculated.
Simulation and Molecular Dynamics (MD) of proteins
Protein structure of anti-apoptotic proteins including 
BCL-2, BCL-XL, and MCL-1 were obtained from the 
RCSB protein data bank with PDB ID: 2W3L, 2YXJ, and 
3KZ0, respectively. PubChem compound databank (from 
National Center for Biotechnology Information) was 
used to obtain the structure of TQ with CID: 10281. For 
docking simulations, by applying the automated docking 
tool (AutoDock), the hetero atoms were removed and 
H-atoms were added to the protein structures.25 MD 
simulation of BCL-2, BCL-XL, and MCL-1 in absence of 
TQ was done by Gromacs software v. 4.5.4.
Molecular docking
Docking simulation studies were conducted on three 
anti-apoptotic proteins and TQ using Lamarckian genetic 
algorithm (LGA) method26 with automated docking tool 
(AutoDock 4.2.3 version). For each protein, a virtual 
network with x,y,z dimensions was created, though the 
size of the box has been changed depending on the TQ 
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size. AutoDock grids were calculated for regularly spaced 
points at intervals of 0.375 A° contained within a cube 
based on the BCL-2, BCL-XL, and MCL-1. Other docking 
parameters were left at the software’s default values set. 
LGA was selected to specify the best conformations in 200 
independent trials of each TQ. Also, the LigPlot plus v.2.1 
software was used to describe protein–ligand interactions 
between the TQ and amino acids.
MD simulation of protein-ligand complexes
MD simulation of BCL-2, BCL-XL, and MCL-1 docked 
with TQ was ran by Gromacs v.4.5.4 software as described 
previously.27 The temperature was set to 300 K for all the 
simulation times. In this study, docking and dynamic 
simulations were performed using bit system with Intel® 
CoreTM i7 CPU Server.
Statistical analysis
Flowcytometry analysis was performed with GraphPad 
Prism 5 software. All the data were analyzed using 
Statistical Package for the Social Sciences software, 
version 22 (SPSS, Inc., Chicago, IL, USA). Inhibitory 
concentration of 50% (IC50) was calculated by the Probit 
procedure. The alkaline comet assay parameters were 
calculated by one-way ANOVA followed by Tukey post 
hoc test. Paired-sample t test was used for MD analysis. P 
value less than 0.001 was considered significant.
Results and Discussion
Today, extensive studies have been carried out to reduce 
the mortality and morbidity of cancer diseases. During 
recent years, plant drugs and their derived compounds 
have attracted the attention of many scientists.28 Some 
studies have revealed that some of these compounds are 
able to induce or inhibit apoptosis in tumor cells.29
Our findings showed that TQ can induce apoptosis 
strongly in PC3 cells. Figure 1 shows the cytotoxicity 
effects of TQ on PC3 cells. TQ declined the cell 
viability percentage gradually with the elevation of TQ 
concentration after 48 h. In our study, the IC50 value of 
TQ was 40µM which is in line with previous study.30 It is 
reported that TQ can induce a significant up-regulation of 
reactive oxygen species (ROS) expression and free radicals 
in PC3 cells which lead to catalyze oxidation of lipids and 
oxidize cysteine residues in proteins accompanied by 
Figure 1. Inhibitory effects of TQ on PC3 cells viability. The viability of PC3 
cells was measured by MTT assay for 48h at various concentrations of TQ. 
The data are expressed as mean ± SD three independent observations.
altering protein structure and function. These changes 
due to ROS may lead to growth inhibition.31 Therefore, 
the reduction in PC3 cells viability in our study can result 
from, at least partly, ROS expression and free radicals. 
In the present study, the effects of TQ at different 
concentrations on DNA fragmentation of PC3 cells were 
surveyed by comet assay (Table 1, Figure 2). The tail/
head ratios of DNA were elevated by a dose dependent 
manner of TQ and maximized at IC50concentration (40 
µM) for negative control and treated cells. The ratio of the 
tail to head diameter on image D was higher, compared 
to other images. The tail/head cell ratio diameter is 
regarded as an appropriate criterion to determine the 
intensity of breakage. The ratios less than 10% displayed 
minor damage while higher ratios were considered as an 
indicator of severe or major damage. In our study, positive 
control (cells treated with 50 µM H2O2) had the longest 
tail which implied severe damage of the genome (Table 1). 
In the present study, the concentrations higher than IC50 
led to cell death and determination of genome breakage 
was not assessed by comet assay. Also, our results show 
that the concentration of 40 µM has inflicted the most 
damage on PC3 cancer cells (Table 1). 
DNA fragmentation is a hallmark of apoptosis that 
increasing via ROS production by TQ treated in PC3 
cells.32 Therefore, in the present study DNA-damage can 
take place by ROS production which induces apoptosis. 
Figure 3 represents the percentage of apoptosis and 
necrosis after treating the cells at different concentrations 
of TQ (0, 20, 30, and 40 µM) related to control cells. 
Table 1. Genotoxicity Effects of TQ on PC3 Cells
Parameter n Control (A) 20 µM (B) 30 µM (C) 40 µM (D) H2O250 µM (E)
Head DNA 100 43.3±0.7 8.2±0.2a 3.4±0.3ab 4.6±0.5ab 6.6±0.5ac
Tail DNA 100 0.8±0.1 2.0±0.1a 4.3±0.1ab 10.2±1.3abc 15.0±1.1abc
Head DNA% 100 98.2±0.1 79.7±0.7a 40.4±1.0ab 33.5±0.3abc 32.8±0.5abc
Tail DNA% 100 1.8±0.1 20.3±0.7a 59.6±1.0ab 66.5±0.3abc 67.2±0.5abc
A, B, C, and D are treated groups with 0 (negative control), 20, 30, and 40 µM of TQ respectively. E is positive control, a treated group with 50 µM H2O2. Head 
DNA; amount of DNA in the comet head, Tail DNA; amount of DNA in the comet tail, Head DNA%; percentage of DNA in the comet head to comet tail, and 
Tail DNA%; percentage of DNA in the comet tail to comet head. Statistical analysis was calculated by One-way ANOVA test. Each point represents mean ± SD.
aP < 0.001 compared with group A; bP < 0.001 compared with group B; cP < 0.001 compared with group C.
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Our results showed that the percentage of apoptosis was 
elevated more than that of necrosis which is in line with 
the previous study in GlioblastomaT-98G cells line.33
Also, Zhang et al showed that TQ can induce 
apoptosis via endoplasmic reticulum stress-dependent 
mitochondrial pathway, mitochondrial dysfunction, 
and activating the mitochondrion-mediated apoptotic 
pathway through reducing MCL-1 and MCL-XL, elevating 
BAX, AIF, and releasing cytochrome c.34 It is reported that 
using MD simulation studies with Panax ginseng derived 
compounds can strongly attach to three anti-apoptotic 
proteins including MCL-XL, MCL-1, and BCL-2 and 
inhibit their activities.35 In this study, MD simulation and 
docking results showed that TQ can strongly affect the 
MD of MCL-XL, MCL-1, and BCL-2.
Table 2 shows the binding energy (BE), final 
intermolecular energy (FIE), and estimated inhibition 
constant (EIC) of BCL-2, BCL-xl and MCL-1. According 
to our docking results, the lowest value of ΔG (BE) was 
between BCL-XL protein and TQ (Table 2). Therefore, the 
binding affinity of TQ to BCL-XL is higher than BCL-2 
and MCL-1.
The LigPlot plus results (Figure 4) showed that TQ 
forms eight, six, and eight hydrophobic bonds on residues 
of BCL-2, MCL-1, and BCL-XL, respectively. However, no 
hydrogen bond was found between TQ and them.
Figure 5 shows the active sites of BCL-2, BCL-XL and 
MCL-1 molecules with lowest energy which are connected 
to TQ.
A common criterion to assess the molecular dynamic 
simulation and also to validate its accuracy is determining 
the root mean-square deviation (RMSD) value of the 
protein backbone compared to the initial structure during 
simulation. This parameter is considered as an indicator 
of the simulation quality and also attainment or non-
attainment of the equilibrium state in the simulation 
system. When a simulation is running, the more RMSD 
for one atom or a group of atoms indicate that their 
structures have more variations.36
According to Table 3, MCL-1 molecule shows the 
highest variation in RMSD which has been increased 
in the presence of TQ. In the presence of TQ, RMSD of 
BCL-XL protein was reduced, subsequently, the structure 
changes decreased and the molecule became more stable. 
Therefore, it can be concluded that TQ has the more 
powerful inhibition effect on BCL-XL than BCL-2 and 
MCL-1.
To assess the oscillation of each residue, we measured 
root mean square fluctuation (RMSF) to observe the 
flexibility of key residues. RMSF values in the presence of 
Figure 2. Genotoxicity effects of TQ on PC3 cells. (A) Negative control cells (without any tail), (B-D) cells treated with 20, 30, 40 µM concentrations of TQ 
respectively, € Cells treated with H2O2.
Figure 3. Apoptotic effects of TQ on PC3 cells after 48 h compared with control group using flowcytometry procedure. A; Negative control cells, B-D; cells treated 
with 20, 30 and 40 µM of TQ respectively.
Table 2. Molecular interaction between TQ and BCL-2, BCL-XL, and MCL-1
Receptor BE kcal/mol FIE kcal/mol EIC μM
Interaction bonds
Hydrogen Bonding Hydrophobic Bonding
BCL-2 -4.65 -5.55 388.7 - Tyr139, Arg142, His143, Glu138, Ala90, Arg86, Phe89, Trp135
BCL-XL -5.89 -6.79 47.94 - Pro116, Gly117, Ala119, Trp169, Arg165, Tyr120
MCL-1 -4.64 -5.53 397.2 - Glu16, Asn223, Asn17, Gly219, Tyr21, Arg215, Val216, Tyr20
Abbreviations: BE, binding and Energy (kcal/mol); FIE, final intermolecular energy (kcal/mol); EIC, estimated inhibition constant (μM).
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TQ for the BCL-2 and MCL-1 increased but for BCL-XL 
decreased (Table 3). 
Radius of gyration (Rg) is a scale of the protein radius. 
For globular proteins, the more Rg means the less 
compaction of the protein structure and more function. 
In the presence of an effective drug, Rg of the protein 
changes and subsequently its structure is altered.37 This 
study showed that, TQ could decrease the Rg properties 
of these anti-apoptotic factors significantly. But, the most 
effect of TQ was on BCL-XL and MCL-1 (Figure 6 and 
Table 3).
The variations in the secondary structures of MCL-1, 
BCL-XL, and BCL-2 and the values of these variations as 
a single molecule or in complex with TQ are displayed 
in Table 4. According to the variation in the secondary 
structure parameter of the studied proteins, it seems that 
when TQ binds to BCL-XL, alpha-helix structure of the 
protein decreases and Bend, Turn and Coil structures 
Figure 4. Analyzed protein–ligand interactions BCL-2 (A), BCL-XL (B), and 
MCL-1 (C).
Figure 6. Radius of gyration (Rg) for BCL-2 (A), BCL-XL (B) and MCL-1 (C). 
Blue color; simulated anti-apoptotic factors in the absence of TQ and red 
color; simulated anti-apoptotic factors in the presence of TQ. Statistical 
analysis was calculated by Paired-sample t test. Each point represents 
mean±SD. a P < 0.001 compared with Blue color.
Figure 5. Three-dimensional structure of docked molecules between TQ and 
BCL-2 (A), BCL-XL (B), and MCL-1 (C).
Table 3. Molecular dynamic parameters
Protein Rg RMSD RMSF
Bcl-2
G1 2.22±0.020 0.58±0.112 0.190±0.061
G2 2.21±0.033
a 0.25±0.057a 0.250±0.080a
Bcl-xl
G1 1.96±0.016 0.68±0.043 0.205±0.072
G2 1.40±0.005
a 0.32±0.010a 0.155±0.080a
Mcl-1
G1 2.89±0.023 0.27±0.04 0.160±0.056
G2 2.48±0.027
a 0.68±0.15a 0.330±0.120a
Abbreviations: G1, simulation before docking; G2, simulation after docking; 
Rg, Radius of gyration; RMSF, root mean square fluctuation; RMSD, root 
mean-square deviation. 
Statistical analysis was calculated by paired-sample t test. Each point 
represents mean ± SD. 
a P< 0.001 compared with group G1.
Table 4. The variations in secondary structure of MCL-1, BCL-XL and BCL
Protein Coil Bend Turn α-Helix
Bcl-2
G1 41.87±2.09 14.10±3.20 22.45±4.06 201.86±3.88
G2 42.13±2.18
a 16.95±2.94a 21.31±4.02a 201.70±3.87
Bcl-xl
G1 38.96±1.7 13.21±3.20 24.87±4.80 199.56±6.03
G2 19.45±1.7
a 7.45±2.41a 11.62±3.65a 194.92±4.16a
Mcl-1
G1 47.36±2.07 18.42±2.90 22.58±3.75 244.76±3.17
G2 47.47±2.45 22.22±4.45
a 23.75±4.76a 239.90±4.18a
Abbreviations: G1, simulation before docking; G2, simulation after docking. 
Statistical analysis was calculated by paired-sample t test. Each point 
represents mean±SD. 
a P < 0.001 compared with group G1.
decrease significantly (Table 4). Since alpha helix and 
beta-sheet structures exist in structural regions of proteins 
and turn and coil structures mostly exist in functional 
regions.38 It is hypothesized that in this state, BCL-XL 
is less effective. MCL-1 and BCL-2 molecule displayed 
fewer variations than BCL-XL. However, some of these 
variations are significant but the biggest 2D structure 
variation is related to BCL-XL.
Conclusion
This study showed that TQ at the concentrations close to 
IC50 can damage PC3 PC cells and also induce apoptosis 
more than necrosis. Molecular docking results and analysis 
revealed that TQ makes more stable bonds with BCL-XL 
than BCL-2 and MCL-1. RMSD data indicated that TQ 
inhibits BCL-XL non-competitively, so by inhibiting BCL-
XL and less MCL-1, TQ can induce apoptosis. MD results 
indicated that TQ has the lowest influence on MCL-1. 
The changes in the secondary structure showed that TQ 
exerts drastic changes over BCL-Xl molecule by reducing 
the effective 2D structures. Taken together, our study 
revealed that TQ induces apoptotic effects by inhibiting 
the anti-apoptotic factor BCL-XL protein compared to 
other studied factors.
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